Buy Piramal Healthcare; 15% upside expected: Gurunath Mudlapur

Gurunath Mudlapur, Director, Atherstone Capital Markets Ltd. in an interview with ET Now talks about Piramal.

What is your call on Piramal?

I think the company is going to be getting a lot cash because of this deal plus the management has always been wise to create value for their business so considering these two important facts I think and the market sentiments remain good for the sector I think it’s a buy for the stock at this stage.

What is your target there?

I think at least another 15% from the current level that is 540 from their 15% more that is what we are expecting.